To the best of our knowledge, this is the first report to show alterations in the levels of growth factors such as IL-7, IL-9, IL-17A, VEGF, basic FGF, G-CSF, and GM-CSF in adolescents with MDD during eight weeks of clinical follow-up. This evidence concerns the gene IL7 and major depressive disorder.